SEC Form 4 · accession 0001645627-17-000063
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 11:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2017 | P | 1,000 | $0.0639 | A | 20,787,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0639 | A | 20,788,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0639 | A | 20,789,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0638 | A | 20,790,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,791,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,792,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,793,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,794,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0631 | A | 20,795,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,796,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,797,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,798,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0631 | A | 20,799,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0637 | A | 20,800,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0635 | A | 20,801,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0635 | A | 20,802,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0633 | A | 20,803,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0633 | A | 20,804,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0633 | A | 20,805,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0632 | A | 20,806,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0633 | A | 20,807,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,808,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,809,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,810,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,811,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.06 | A | 20,812,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0599 | A | 20,813,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0599 | A | 20,814,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0599 | A | 20,815,949 | D | |
| Common Stock | May 16, 2017 | P | 1,000 | $0.0599 | A | 20,816,949 | D |
Table II — derivative securities
No Table II lines on this filing.